Global Retirement Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.4M | Buy |
+73,217
| New | +$15.8M | 0.28% | 71 |
|
|
2025
Q4 | $25.3M | Buy |
110,681
+13,482
| +14% | +$3.07M | 0.45% | 47 |
|
|
2025
Q3 | $22.5M | Buy |
97,199
+502
| +0.5% | +$102K | 0.5% | 37 |
|
|
2025
Q2 | $17.9M | Buy |
+96,697
| New | +$18M | 0.44% | 44 |
|
|
2024
Q4 | $15.5M | Buy |
87,116
+6,769
| +8% | +$1.24M | 0.44% | 43 |
|
|
2024
Q3 | $15.9M | Sell |
80,347
-1,156
| -1% | -$216K | 0.48% | 39 |
|
|
2024
Q2 | $14M | Buy |
81,503
+7,260
| +10% | +$1.2M | 0.44% | 43 |
|
|
2024
Q1 | $13.5M | Sell |
74,243
-144
| -0.2% | -$24.8K | 0.5% | 37 |
|
|
2023
Q4 | $12M | Buy |
74,387
+1,624
| +2% | +$237K | 0.5% | 38 |
|
|
2023
Q3 | $10.7M | Sell |
72,763
-3,817
| -5% | -$560K | 0.54% | 35 |
|
|
2023
Q2 | $10.3M | Buy |
76,580
+342
| +0.4% | +$50.2K | 0.5% | 36 |
|
|
2023
Q1 | $11.4M | Buy |
76,238
+43,560
| +133% | +$6.66M | 0.6% | 30 |
|
|
2022
Q4 | $5.28M | Buy |
32,678
+5,110
| +19% | +$784K | 0.36% | 56 |
|
|
2022
Q3 | $4.04M | Buy |
27,568
+2,312
| +9% | +$332K | 0.31% | 71 |
|
|
2022
Q2 | $3.87M | Buy |
25,256
+541
| +2% | +$82.7K | 0.31% | 76 |
|
|
2022
Q1 | $3.69M | Buy |
+24,715
| New | +$3.59M | 0.29% | 81 |
|
|
2021
Q4 | – | Sell |
-20,883
| Closed | -$2.25M | – | 257 |
|
|
2021
Q3 | $2.25M | Buy |
20,883
+3,224
| +18% | +$368K | 0.22% | 97 |
|
|
2021
Q2 | $1.99M | Sell |
17,659
-250
| -1% | -$28.2K | 0.2% | 112 |
|
|
2021
Q1 | $1.94M | Sell |
17,909
-613
| -3% | -$65.6K | 0.23% | 93 |
|
|
2020
Q4 | $1.99M | Buy |
18,522
+3,529
| +24% | +$339K | 0.25% | 80 |
|
|
2020
Q3 | $1.31M | Sell |
14,993
-909
| -6% | -$85.6K | 0.19% | 115 |
|
|
2020
Q2 | $1.56M | Buy |
15,902
+2,385
| +18% | +$210K | 0.25% | 86 |
|
|
2020
Q1 | $1.03M | Sell |
13,517
-739
| -5% | -$62.9K | 0.19% | 113 |
|
|
2019
Q4 | $1.26M | Sell |
14,256
-46
| -0.3% | -$3.82K | 0.19% | 113 |
|
|
2019
Q3 | $1.08M | Buy |
14,302
+2,568
| +22% | +$176K | 0.18% | 126 |
|
|
2019
Q2 | $853K | Buy |
11,734
+7,092
| +153% | +$557K | 0.16% | 125 |
|
|
2019
Q1 | $374K | Sell |
4,642
-301
| -6% | -$24.6K | 0.09% | 195 |
|
|
2018
Q4 | $456K | Buy |
4,943
+416
| +9% | +$36.6K | 0.12% | 173 |
|
|
2018
Q3 | $428K | Sell |
4,527
-88
| -2% | -$8.35K | 0.1% | 185 |
|
|
2018
Q2 | $428K | Sell |
4,615
-7
| -0.2% | -$684 | 0.11% | 182 |
|
|
2018
Q1 | $437K | Sell |
4,622
-270
| -6% | -$29.7K | 0.12% | 177 |
|
|
2017
Q4 | $473K | Buy |
4,892
+405
| +9% | +$38.2K | 0.13% | 149 |
|
|
2017
Q3 | $399K | Buy |
4,487
+1,088
| +32% | +$82.8K | 0.17% | 125 |
|
|
2017
Q2 | $246K | Buy |
3,399
+780
| +30% | +$52.4K | 0.12% | 173 |
|
|
2017
Q1 | $171K | Sell |
2,619
-321
| -11% | -$20.2K | 0.1% | 203 |
|
|
2016
Q4 | $184K | Buy |
+2,940
| New | +$179K | 0.12% | 152 |
|
Other funds holding ABBV
Global Retirement Partners's ABBV Position: Q2 2026 in Review
Global Retirement Partners opened a new position in AbbVie (ABBV) in Q2 2026: 73,217 shares worth $18.4M. The stake represents 0.28% of the portfolio and ranks #71 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in ABBV as recently as Q4 2025.
Global Retirement Partners first reported a position in ABBV in Q4 2016 and has held it in 36 quarters since. The position peaked at $25.3M in Q4 2025. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Global Retirement Partners held 73,217 shares of AbbVie worth $18.4M as of Q2 2026.
- AbbVie was a new Global Retirement Partners position in Q2 2026.
- AbbVie made up 0.28% of Global Retirement Partners's portfolio in Q2 2026, its #71 holding.
- Global Retirement Partners first reported a position in AbbVie in Q4 2016 and has held it in 36 quarters since.
- Global Retirement Partners's AbbVie position peaked at $25.3M in Q4 2025.
- 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.